DaVita HealthCare Partners Forecast, price target & analysts
DaVita HealthCare Partners Target price 2025 - Analyst rating & recommendation
DaVita HealthCare Partners Classifications & Recommendation:
DaVita HealthCare Partners Price Target
| Target Price | $152.14 |
| Price | $128.41 |
| Potential |
18.48%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target DaVita HealthCare Partners 2026 .
The average DaVita HealthCare Partners target price is $152.14.
This is
18.48%
register free of charge
$195.30
52.09%
register free of charge
$138.37
7.76%
register free of charge
|
|
| A rating was issued by 17 analysts: 1 Analysts recommend DaVita HealthCare Partners to buy, 10 to hold and 6 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the DaVita HealthCare Partners stock has an average upside potential 2026 of
18.48%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 12.82 | 13.58 |
| 5.56% | 5.96% | |
| EBITDA Margin | 20.90% | 20.72% |
| 8.14% | 0.87% | |
| Net Margin | 7.31% | 6.00% |
| 28.26% | 17.88% |
11 Analysts have issued a sales forecast DaVita HealthCare Partners 2025 . The average DaVita HealthCare Partners sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an DaVita HealthCare Partners EBITDA forecast 2025. The average DaVita HealthCare Partners EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 DaVita HealthCare Partners Analysts have issued a net profit forecast 2025. The average DaVita HealthCare Partners net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 10.73 | 10.97 |
| 44.61% | 2.24% | |
| P/E | 11.70 | |
| EV/Sales | 1.38 |
11 Analysts have issued a DaVita HealthCare Partners forecast for earnings per share. The average DaVita HealthCare Partners EPS is
This results in the following potential growth metrics and future valuations:
DaVita HealthCare Partners...
Current DaVita HealthCare Partners Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Locked
➜
Locked
|
Locked | Oct 09 2025 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Sep 10 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | May 19 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Feb 18 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 31 2024 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Oct 07 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 09 2025 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Sep 10 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Aug 07 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
May 19 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Feb 18 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 31 2024 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Oct 07 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
